Dr. Ron Waksman

New Capabilities

Cardiologist at MedStar Heart and Vascular Institute; professor at Georgetown University

The FDA on September 21 approved the first drug-eluting balloon for coronary use in the United States. Cordis' SELUTION SLR expands inside a narrowed artery, releases the drug sirolimus into the vessel wall for up to 90 days, and is removed — no permanent implant stays behind.

Updated 1 hour ago